Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma. [electronic resource]
Producer: 20050405Description: 1055-9 p. digitalISSN:- 0391-4097
- Adenoma -- complications
- Adrenocorticotropic Hormone -- metabolism
- Cabergoline
- Dopamine Agonists -- pharmacology
- Ergolines -- pharmacology
- Humans
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Pituitary ACTH Hypersecretion -- drug therapy
- Pituitary Neoplasms -- complications
- Receptors, Dopamine D2 -- analysis
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.